Metabolic and Infectious Diseases in La Réunion (the REUNION Population-based Study)

ConditionsInfectious Disease Cardiovascular Diseases General Population Metabolic Disease

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18-67

SponsorInstitut National de la Santé Et de la Recherche Médicale, France

About this trial

The aim of the present study is to determine the prevalence of cardiometabolic and infectious disease in La Reunion (french oversea department and region of France).

Known or suspected risk factor for these diseases will also be assessed, such as microbiota, cognitive impairement, social inequalities, and genetics.

Eligibility criteria

Qualifiers

18-67 years

given consent for genetic analysis,

written consent for participating in the study

Disqualifiers

judicial protection or guardianship

Trial design

Treatments tested in this trial

Blood, DNA, feces, urine, hair and skin microbiota collection

Treatment groups

2,000 Participants

are divided into 1 treatment group

Sponsors and collaborators

Institut National de la Santé Et de la Recherche Médicale, France

Lead sponsor

Source ClinicalTrials.gov